Ischemic cardiomyopathy | Non-ischemic cardiomyopathy | |||||||
---|---|---|---|---|---|---|---|---|
Univariable analysis | Adjusted modela | Univariable analysis | Adjusted modela | |||||
Hazard ratio | P value | Hazard ratio | P value | Hazard ratio | P value | Hazard ratio | P value | |
LVEF (+1%) | 1.00 [0.96–1.04] | 0.94 | 1.00 [0.95–1.04] | 0.86 | 0.97 [0.90–1.05] | 0.40 | 0.97 [0.90–1.04] | 0.42 |
NSVT | 26.9 [6.33–114] | < 0.0001 | 26.1 [6.13–111] | < 0.0001 | 4.62 [1.33–16.1] | 0.016 | 4.41 [1.26–15.4] | 0.020 |
NYHA class (+1) | 0.86 [0.46–1.62] | 0.64 | 1.17 [0.35–3.76] | 0.80 | ||||
Atrial fibrillation | 1.18 [0.53–2.59] | 0.69 | 0.84 [0.24–3.00] | 0.79 | ||||
Hemoglobin (+1 g/dL) | 1.12 [0.91–1.43] | 0.30 | 0.90 [0.63–1.33] | 0.58 |